No 03 2019
Updated: January 31, 2025, 09:23 am
Published: September 1, 2019
Updated: January 31, 2025, 09:23 am
Published: September 1, 2019
Top stories
Biotech article – July 13, 2026
BioArctic’s partner Eisai has presented new data at the 2026 Alzheimer’s Association International Conference (AAIC), held in London, July 12-15, demonstrating that the Leqembi (lecanemab) subcutaneous autoinjector (SC-AI) formulation offers efficacy and safety comparable to intravenous (IV) administration in people with early Alzheimer’s disease.
Science News – July 13, 2026
A landmark study led from Lund University has shown that transplanting stem-cell derived dopamine progenitor cells into the brain is feasible. Eight patients were transplanted in the first clinical trial, and no serious side effects directly linked to the transplanted cells were seen during the first year of follow up.
New Market – July 13, 2026
The new facility, located at Uppsala Business Park, will serve as a European centre for chromatography resin development, process development, technical support and customer collaboration.
Europe – July 13, 2026
Spanish biochemist and molecular biologist Salvador Aznar Benitah’s research focuses on how adult stem cells function in normal conditions, aging, and cancer, with particular interest in epigenetics, circadian rhythms, and the mechanisms that allow certain cancer cells to initiate metastasis.
Related posts
This site uses cookies